Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species. | Sci Adv | 2023 | 36791195 | PubTator, text mining | PubMed |
| Interactomes of Glycogen Synthase Kinase-3 Isoforms. | J Proteome Res | 2023 | 36779422 | PubTator, text mining | PubMed |
| GAB1::ABL1 fusions define a distinctive soft tissue neoplasm, with variable perineurial differentiation, and a predilection for children and young adults. | Genes Chromosomes Cancer | 2023 | 36744864 | PubTator, text mining | PubMed |
| Diagnostic and therapeutic value of biomarkers in urosepsis. | Ther Adv Urol | 2023 | 36744043 | PubTator, text mining | PubMed |
| Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson's disease. | NPJ Parkinsons Dis | 2023 | 36732514 | PubTator, text mining | PubMed |
| Mechanisms underlying pathological scarring by fibroblasts during wound healing. | Int Wound J | 2023 | 36726192 | PubTator, text mining | PubMed |
| Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. | Nat Commun | 2023 | 36720864 | PubTator, text mining | PubMed |
| Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer. | J Clin Invest | 2023 | 36647832 | PubTator, text mining | PubMed |
| Targeted therapy for head and neck cancer: signaling pathways and clinical studies. | Signal Transduct Target Ther | 2023 | 36646686 | PubTator, text mining | PubMed |
| Employing in silico investigations to determine the cross-kingdom approach for Curcuma longa miRNAs and their human targets. | Beni Suef Univ J Basic Appl Sci | 2023 | 36644780 | PubTator, text mining | PubMed |
| Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5. | Int J Gen Med | 2023 | 36644568 | PubTator, text mining | PubMed |
| Interleukin-13 and its receptor are synaptic proteins involved in plasticity and neuroprotection. | Nat Commun | 2023 | 36639371 | PubTator, text mining | PubMed |
| GAB1 as a Marker of Recurrence in Anterior Skull Base Meningioma. | Neurosurgery | 2023 | 36637273 | PubTator, text mining | PubMed |
| Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes. | J Clin Invest | 2023 | 36633903 | PubTator, text mining | PubMed |
| Genetic variations in patient with Parry-Romberg syndrome. | Sci Rep | 2023 | 36624141 | PubTator, text mining | PubMed |
| Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors. | Pediatr Neurosurg | 2023 | 36617415 | PubTator, text mining | PubMed |
| Signaling pathways in brain tumors and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36596785 | PubTator, text mining | PubMed |
| Measurement of FGFR3 signaling at the cell membrane via total internal reflection fluorescence microscopy to compare the activation of FGFR3 mutants. | J Biol Chem | 2023 | 36581204 | PubTator, text mining | PubMed |
| Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling. | J Clin Invest | 2023 | 36548088 | PubTator, text mining | PubMed |
| Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. | Nat Genet | 2023 | 36539618 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=13